Summary
Overview
Work History
Education
Skills
Timeline
Generic
Xiaoyue Wang

Xiaoyue Wang

Ph.D., Executive MBA
Heidelberg

Summary

Agile Mindset, Passion for Business Opportunities, and Business Development to transform biotechnology to save the patient life, excited by Innovation. Strong business acumen with scientific knowledge in healthcare and am looking for new challenges.

Overview

10
10
years of professional experience
13
13
years of post-secondary education
4
4
Languages

Work History

Director of Business Development Oncology

Vela Diagnostics Germany GmbH
Heidelberg
2021.09 - Current
  • Developed and implemented a Market Entry Strategy for Oncology Diagnostics products in the EMEA market.
  • Developed IVDR registration strategy.
  • Engaged with KOLs of Oncologists and Pathologists and set up clinical studies across different countries in EMEA, e.g., Germany, France, Italy, Portugal, and Turkey.
  • Actively listened to customers, handled concerns quickly, and escalated major issues to R&D to improve the products.
  • Managed cross-country sales teams and collaborated with the support team.
  • Responsible for the P&L for the Oncology product line across the EMEA market.
  • Successfully installed the first reference customer in EMEA.

Vice President of Business Development and Sales

Molecular Health
Heidelberg
2019.01 - 2021.08
  • International business development activities related to biotech companies, investors, clinical diagnostic labs, distributors, and pharmaceutical companies.
  • Developed country-specific CDx or IVD strategies for market entries of CE-IVD products.
  • Successfully developed go-to-market strategy and implementation for CE-IVD and AI-driven digital products.
  • Successful market expansion drove strategic alliance partnership growth more than twice yearly.
  • Achieved end-to-end B2B, B2C Business Development strategic alliances deal with more than two times yearly growth.
  • Team management responsibilities, cross-continental cross-culture local representatives.

Business Development & Sales Manager

Molecular Health
Heidelberg
2017.03 - 2018.12
  • Identified KOL physicians, e.g., oncologists/human geneticists in leading clinics and clinical diagnostic labs, and arranged face-to-face meetings/seminars
  • Identified partners for creating joint ventures, collaborations, and local distributions, followed by LOI and cooperation agreement contract negotiations.
  • Cross-function communication with legal counsel and national authorities, e.g., PMDA, CFDA.
  • Developed comprehensive, cross-cultural market entry/sales business strategies for new international markets.
  • Successfully entered multiple markets in APAC and increased sales by 25%, e.g., Japan, Hong Kong, and South Korea.
  • Identified customer needs and coordinated innovative strategies to create a new BRCA testing product with the product development team.
  • Created reports and presentations are detailing business development activities.

NGS Platform Leader

Perkin Elmer
Suzhou
2016.01 - 2017.01
  • Owned and managed about 600,000 € budget, installed all equipment, and hired team members.
  • Built NGS technology platform, designed gene panels for diagnostic applications in inherited diseases, and led team to set up data analysis server and establish clinical data analysis pipeline.
  • Hired and managed an NGS team consisting of 12 staff, including technicians, bioinformaticians, and genetic counselors.
  • Conducted clinical test validation and generated validation reports for clinical tests with the team.

Senior Scientist

German Cancer Research Center (DKFZ)
Heidelberg
2011.10 - 2015.06
  • Managed technicians and coached Master Students to conduct experiments in a laboratory environment for metabolism cancer research purposes.
  • Simultaneously managed several complex projects, meeting all pertinent milestones.
  • Drove ongoing advances in cancer & metabolic type II diabetes, NGS, and data analysis, planning and managing projects, with results presented at numerous seminars and scientific meetings.

R&D Scientist - Internship

PROCTER & GAMBLE (P&G)
Brussels
2011.08 - 2011.10
  • Developed innovative testing methods to improve product market research strategies. Initiated and organized several company meetings with colleagues from both product design and market research departments.
  • Commended by managers for outstanding work and contributions to the department.

Education

ESSEC & MANNHEIM Executive MBA - Business Administration And Management

Mannheim Business School
Mannheim
2020.10 - 2022.06

ESSEC & MANNHEIM Executive MBA - Business Administration And Management

ESSEC Business School
Paris, France
2020.10 - 2022.06

Ph.D. - Genetics And Developmental Biology

Max-Planck Instittue For Developmental Biology
Tübingen
2007.04 - 2011.03

Master of Science - Graduate School of Medicine

Kyoto University
Kyoto, Japan
2005.04 - 2007.03

Bachelor of Science - Applied Life Science

Kyoto University
Kyoto, Japan
2001.04 - 2005.03

Skills

    Business development and planning

undefined

Timeline

Director of Business Development Oncology

Vela Diagnostics Germany GmbH
2021.09 - Current

ESSEC & MANNHEIM Executive MBA - Business Administration And Management

Mannheim Business School
2020.10 - 2022.06

ESSEC & MANNHEIM Executive MBA - Business Administration And Management

ESSEC Business School
2020.10 - 2022.06

Vice President of Business Development and Sales

Molecular Health
2019.01 - 2021.08

Business Development & Sales Manager

Molecular Health
2017.03 - 2018.12

NGS Platform Leader

Perkin Elmer
2016.01 - 2017.01

Senior Scientist

German Cancer Research Center (DKFZ)
2011.10 - 2015.06

R&D Scientist - Internship

PROCTER & GAMBLE (P&G)
2011.08 - 2011.10

Ph.D. - Genetics And Developmental Biology

Max-Planck Instittue For Developmental Biology
2007.04 - 2011.03

Master of Science - Graduate School of Medicine

Kyoto University
2005.04 - 2007.03

Bachelor of Science - Applied Life Science

Kyoto University
2001.04 - 2005.03
Xiaoyue WangPh.D., Executive MBA